SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-22-007947
Filing Date
2022-11-21
Accepted
2022-11-21 16:06:13
Documents
65
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannarx_i10q-093022.htm   iXBRL 10-Q 1071425
2 CERTIFICATION cannarx_ex3101.htm EX-31.1 11500
3 CERTIFICATION cannarx_ex3102.htm EX-31.2 11494
4 CERTIFICATION cannarx_ex3200.htm EX-32 4590
  Complete submission text file 0001683168-22-007947.txt   4568199

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cpmd-20220930.xsd EX-101.SCH 39686
6 XBRL CALCULATION FILE cpmd-20220930_cal.xml EX-101.CAL 54350
7 XBRL DEFINITION FILE cpmd-20220930_def.xml EX-101.DEF 136398
8 XBRL LABEL FILE cpmd-20220930_lab.xml EX-101.LAB 275170
9 XBRL PRESENTATION FILE cpmd-20220930_pre.xml EX-101.PRE 230612
59 EXTRACTED XBRL INSTANCE DOCUMENT cannarx_i10q-093022_htm.xml XML 612597
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 221405798
SIC: 2834 Pharmaceutical Preparations